首页> 外国专利> LATS1 Gene Mutation Marker Based Diagnosis of Amyotrophic Lateral Sclerosis

LATS1 Gene Mutation Marker Based Diagnosis of Amyotrophic Lateral Sclerosis

机译:基于肌营养侧面硬化的Lats1基因突变标志性

摘要

The present invention relates to a diagnostic method for amyotrophic lateral sclerosis based on LATS1 gene mutation. The present invention provides an accurate and efficient marker-based diagnostic method for diagnosing amyotrophic lateral sclerosis that lacks effective molecular diagnostic markers. The marker of the present invention can diagnose amyotrophic lateral sclerosis even when a previously reported marker is not found, and suggests a new diagnostic method for amyotrophic lateral sclerosis. The diagnostic method, marker, and use thereof of the present invention are useful in the diagnosis, prediction, treatment and prevention of amyotrophic lateral sclerosis. Furthermore, the LATS1 gene of the present invention can be used to study the onset mechanism of amyotrophic lateral sclerosis and develop a drug for treatment.
机译:[I>本发明涉及基于LATS1基因突变的肌营养侧面硬化的诊断方法。本发明提供了一种精确有效的基于标记的诊断方法,用于诊断缺乏有效的分子诊断标志物的肌萎缩侧面硬化。即使未发现先前报告的标记,本发明的标记也可以诊断肌营养的侧面硬化,并且表明肌营养侧面硬化的新诊断方法。本发明的诊断方法,标记及其用途可用于肌营养侧面硬化的诊断,预测,治疗和预防。此外,本发明的 Lats1 基因可用于研究肌营养侧面硬化的起始机制,并开发治疗药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号